APUS
XASEAPIMEDS PHARMACEUTICALS US I
Avg. sentiment
0.60bullish
1 news · 90d
7d trend
——
0 news · vs previous 7d (—)
Breakdown
↑ 1• 0↓ 0
Sentiment velocity
+0.000→/day
Acceleration —
Sentiment scores computed by AI · Not investment advice.
No price data available for this ticker.
Track $APUS sentiment without checking the page.
Top-discussed tickers and the AI sentiment we read. Not advice.
News · 1
How did the price react? →- BusinessWire5/5/2026, 6:07:00 PMApimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
Apimeds Pharmaceuticals US (APUS) announced a settlement with Inscobee Inc. and Apimeds Inc., resolving all disputes stemming from its December 2025 merger with MindWave Innovations. The settlement enables completion of the merger, closing of a previously disclosed $100 million PIPE financing, and advancement of the Lōkahi Therapeutics Apitox program. No financial terms of the settlement were disclosed.
Sentiment 0.60Relevance 100%